Product NDC: | 57664-230 |
Proprietary Name: | METHYLPHENIDATE HYDROCHLORIDE |
Non Proprietary Name: | methylphenidate hydrochloride |
Active Ingredient(s): | 20 mg/1 & nbsp; methylphenidate hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-230 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090710 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120329 |
Package NDC: | 57664-230-18 |
Package Description: | 1000 TABLET in 1 BOTTLE (57664-230-18) |
NDC Code | 57664-230-18 |
Proprietary Name | METHYLPHENIDATE HYDROCHLORIDE |
Package Description | 1000 TABLET in 1 BOTTLE (57664-230-18) |
Product NDC | 57664-230 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methylphenidate hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120329 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |